Pfizer CEO “Not At All” In Favour Of US Patent Waiver: Report

By
Mr. Senta
-
0

In an interview with AFP, Bourla said his company, which developed its vaccine with German firm BioNTech, was “not at all” in favour of the call from the United States to waive patent protections for coronavirus jabs.

Pfizer CEO 'Not At All' In Favour Of US Patent Waiver: Report

Pfizer CEO Albert Bourla said he was against a US-backed proposal to waive patents on Covid vaccines



Brussels:

Pfizer CEO Albert Bourla on Thursday said he was against a US-backed proposal to waive patents on Covid-19 vaccines, saying production should be ramped up in existing facilities instead.

In an interview with AFP, Bourla said his company, which developed its vaccine with German firm BioNTech, was “not at all” in favour of the call from the United States to waive patent protections for coronavirus jabs.

(Except for the headline, this story has not been edited by our staff and is published from a syndicated feed.)

RELATED ARTICLESMORE FROM AUTHOR

LEAVE A REPLY

Please enter your comment!
Please enter your name here

All the data shown above will be stored by www.rajpostexam.com on https://www.rajpostexam.com/. At any point of time, you can contact us and select the data you wish to anonymise or delete so it cannot be linked to your email address any longer. When your data is anonymised or deleted, you will receive an email confirmation. We also use cookies and/or similar technologies to analyse customer behaviour, administer the website, track users' movements, and to collect information about users. This is done in order to personalise and enhance your experience with us. Click here to read our Cookie Policy.